Azelby Robert

Insider profile

Performance

Overall performance
0.8

Performance over holding periods
0.8
30 days 90 days 120 days
Average return -31% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Azelby Robert's trades of ADC Therapeutics SA's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-06-18 2024-06-17 PrS Proposed sale
2,102
474.24
US$4,186,626
2,102 474.24 US$4,186,626
2024-06-18 2024-06-17 S Sale
72,700 +4.4%
95.59
US$2,828,740
72,700 +4.4% 95.59 US$2,828,740